living WELL

Dannels-McClure, Amy; Maerz, Gary
March 2006
PN;Mar2006, Vol. 60 Issue 3, p46
Trade Publication
The article reports on explorations of the use of botulinum toxin A (BTXA) as an option for treating stubborn spasticity and pain following spinal-cord injury (SCI). Its use to treat incontinence and inefficient urine emptying due to spasticity of the bladder as well as a potent inhibitor of pain, are being explored. BTXA's effectiveness and safety has been reported in literature when administered appropriately.


Related Articles

  • First placebo-controlled trial of Botox for incontinence.  // Inside MS;Dec2005/Jan2006, Vol. 23 Issue 6, p34 

    The article reports on a clinical trial of botulinum toxin type A. A study was conducted to determine the effect of botulinum toxin on neurogenic overactive bladder, which is a kind of urinary incontinence associated with multiple sclerosis. Results showed that those who were injected with the...

  • 'Continued success' seen with botulinum injections. Krader, Cheryl Guttman // Urology Times;Dec2014, Vol. 42 Issue 13, p10 

    The article focuses on the continuous consumption of the onabotulinumtoxinA drug by the patients suffering from overactive bladder syndrome and urinary incontinence. Topics discussed includes research conducted by the New York University Langone Medical Center, New York City, clinical trials of...

  • Incontinence.  // Current Medical Literature: Urology;2009, Vol. 15 Issue 3, p79 

    The article discusses research on incontinence. It reference several studies including a comparison between painful bladder syndrome/interstitial cystitis and idiopathic overactive bladder by S. H. Kim et al, the combined effects of behavioral intervention and tolterodine in patients...

  • Conference briefs.  // New Zealand Doctor;10/6/2004, p18 

    Presents the results of several studies on urinary disorders. Efficacy of sacral neuromodulation therapy for restoring voiding in patients who are refractory to other forms of treatment; Impact of pelvic floor muscle training on bladder neck mobility; Role of botulinum toxin type A in managing...

  • Use of Botulinum Toxin A in Adult Neurological Disorders. Schulte-Mattler, Wilhelm J. // CNS Drugs;2008, Vol. 22 Issue 9, p725 

    The protein botulinum neurotoxin A (BoNT/A) is one of seven distinct neurotoxins produced by Clostridium botulinum. BoNT/A blocks cholinergic synapses with an extremely high specificity and potency. Appropriately purified and diluted, BoNT/A serves as a reliable and well tolerated drug that is...

  • Urinary disorders in multiple sclerosis. Two clinical case reports. Nardulli, R.; Losavio, E. // Neurological Sciences;Sep2006 Supplement 4, Vol. 27, ps328 

    After having treated two clinical cases, the management of bladder symptoms in multiple sclerosis is presented. This entails clinical assessment, diagnostic and therapeutic stage. The role of urodynamic evaluation is also evaluated.

  • Podium Session 3: Incontinence, Reconstruction, ED: Postprostatectomy Issues June 29, 2009, 1050-2000.  // Canadian Urological Association Journal;Jui2009 Supplement 1, Vol. 3, pS11 

    The article presents abstracts on postprostatectomy issues which include the promising results of using transvaginal mesh for pelvic organ prolapse repair, comparative study of the tolerability of solifenacin and oxybutynin immediate release in patients with overactive bladder, and the results...

  • Botulinum toxin shows efficacy in detrusor overactivity. Bronstein, Nancy // Urology Times;Jan2010, Vol. 38 Issue 1, p18 

    The article reports on the study which explores the efficacy of botulinum toxin A (Botox) on treating neurogenic detrusor overactivity and urinary incontinence secondary to spinal cord injury or multiple sclerosis. It notes that Botox improves urinary volume and frequency during first detrusor...

  • Botulinum injections show efficacy in refractory OAB. Fernberg, Patricia // Urology Times;10/15/2005, Vol. 33 Issue 13, p10 

    Discusses the findings of a research by Daniel M. Schmid Jr. and colleagues in Switzerland, about the effectiveness of botulinum toxin A injections in patients with overactive bladder refractory (OBA). Reduction in frequency and urgency rates among OBA patients; Improvement in bladder functions;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics